These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 3871663

  • 1. Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2.
    Ramos OF, Masucci MG, Klein E.
    Cell Immunol; 1985 Mar; 91(1):178-92. PubMed ID: 3871663
    [Abstract] [Full Text] [Related]

  • 2. The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytes.
    Ramos OF, Masucci MG, Bejarano MT, Klein E.
    Immunobiology; 1983 Dec; 165(5):403-14. PubMed ID: 6607208
    [Abstract] [Full Text] [Related]

  • 3. Phorbol esters inhibit the functional activation of cytotoxic precursors in mixed lymphocyte cultures.
    Masucci MG, Torsteinsdottir S, Pear W, Carstensen A, Klein E.
    J Immunol; 1984 Oct; 133(4):1755-62. PubMed ID: 6236256
    [Abstract] [Full Text] [Related]

  • 4. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
    Trinchieri G, O'Brien T, Shade M, Perussia B.
    J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
    [Abstract] [Full Text] [Related]

  • 5. Activation of cytotoxic activity of human blood lymphocytes by tumor-promoting compounds.
    Ramos OF, Masucci MG, Klein E.
    Cancer Res; 1984 May; 44(5):1857-62. PubMed ID: 6201264
    [Abstract] [Full Text] [Related]

  • 6. Phorbol ester-induced lymphocyte adherence: selective action on NK cells.
    Argov S, Hebdon M, Cuatrecasas P, Koren HS.
    J Immunol; 1985 Apr; 134(4):2215-22. PubMed ID: 3855930
    [Abstract] [Full Text] [Related]

  • 7. Phorbol ester-inactivation of cloned cytotoxic T lymphocytes: restoration of lytic activity by interleukin 2 and induction of interferon production are separable events.
    Finke JH, Yen-Lieberman B, Scott JW, Proffitt MR, Orosz CG.
    Lymphokine Res; 1985 Apr; 4(4):299-308. PubMed ID: 3930891
    [Abstract] [Full Text] [Related]

  • 8. Phorbol-ester stimulated lysis of weak and nonspecific target cells by cytotoxic T lymphocytes.
    Russell JH.
    J Immunol; 1986 Jan; 136(1):23-7. PubMed ID: 2415619
    [Abstract] [Full Text] [Related]

  • 9. Phorbol esters inactivate the lytic apparatus of cytotoxic T lymphocytes.
    Russell JH.
    J Immunol; 1984 Aug; 133(2):907-12. PubMed ID: 6610713
    [Abstract] [Full Text] [Related]

  • 10. Fucose-activated killer (FAK) cells: anomalous killers with augmented cytotoxic activity.
    Stanková J, Rola-Pleszczynski M.
    J Immunol; 1985 Dec; 135(6):3719-28. PubMed ID: 2415584
    [Abstract] [Full Text] [Related]

  • 11. Phorbol ester induces a differential effect on the effector function of human allospecific cytotoxic T lymphocyte and natural killer clones.
    Bensussan A, Tourvieille B, Chen LK, Dausset J, Sasportes M.
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6642-6. PubMed ID: 3876559
    [Abstract] [Full Text] [Related]

  • 12. K562 killing by K, IL 2-responsive NK, and T cells involves different effector cell post-binding trigger mechanisms.
    Shanahan F, Brogan MD, Newman W, Targan SR.
    J Immunol; 1986 Jul 15; 137(2):723-6. PubMed ID: 3487579
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phorbol ester-stimulated T lymphocytes show enhanced adhesion to human endothelial cell monolayers.
    Haskard D, Cavender D, Ziff M.
    J Immunol; 1986 Sep 01; 137(5):1429-34. PubMed ID: 3091681
    [Abstract] [Full Text] [Related]

  • 16. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB, Gutterman JU, Grimm EA.
    Cancer Res; 1988 Feb 15; 48(4):788-92. PubMed ID: 3257408
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
    McCrady CW, Li F, Grant AJ, Merchant RE, Carchman RA.
    Cancer Res; 1988 Feb 01; 48(3):635-40. PubMed ID: 3257170
    [Abstract] [Full Text] [Related]

  • 20. Phorbol myristate acetate and in vitro T lymphocyte function. III. Selective impairment by PMA of lethal hit delivery by cloned CTL.
    Orosz CG, Roopenian DC.
    Transplantation; 1985 Apr 01; 39(4):411-8. PubMed ID: 3157247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.